Psychedelics Archives - Page 68 of 68

4 minute read

Michael Pollan’s ‘How To Change Your Mind’ Now On Netflix, Here Are Reactions From Experts

July 14, 1:32 PM

Michael Pollan's 2018 book “How To Change Your Mind: What the science of psychedelics teaches us about consciousness, dying, addiction, depression, and transcendence” is available on Netflix (NASDAQ: NFLX).

AWKNF

2 minute read

New Optimi Supply Agreement: Psilocybin For Phase 1 Trial On Microdosing For Wellbeing, No Hallucinogenic Effects

By Lara Goldstein

July 13, 4:22 PM

Canadian psychedelics company Optimi Health Corp. (OTCQX: OPTHF) signed a supply agreement with the Bloom Psychedelic Therapy And Research Centre, a Calgary-based provider of psychedelic-assisted therapies for mental health conditions.

OPTHF

3 minute read

PharmaTher Receives Notice Of Allowance For U.S. Patent Covering Ketamine For Parkinson’s And Motor Disorders Treatment

By Lara Goldstein

July 13, 3:37 PM

Ketamine pharmaceuticals provider PharmaTher Holdings Ltd. (OTCQB: PHRRF) has been granted a Notice of Allowance by the U.S.

PHRRF

4 minute read

Psychedelic Companies With Solid Fundamentals Will Survive A Downturn In The Recession-Ridden Market

By Microdose Psychedelic Insights

July 13, 1:32 PM

Article by Jason Najum. Psychedelic startups face a more challenging time raising capital amid market volatility, the prospect of rate hikes, and recession fears, but that could ultimately help the industry to mature.

ATAI

4 minute read

Invest In The Future Of Medicine Says Berner, CEO Of Cookies At Benzinga’s Psychedelics Capital Conference

By Nicolas Jose Rodriguez

July 12, 2:56 PM

Berner, the famed rapper, co-founder and CEO of the highly successful cannabis and clothing brand, Cookies, was one of the main speakers at Benzinga's Psychedelics Capital Conference last April at the Fontainebleau Miami Beach Hotel.

GAEGF

2 minute read

LFTD Partners Lowers Its Secured Debt, Here Are The Details

By Vuk Zdinjak

July 11, 11:03 AM

LFTD Partners Inc. (OTCQB: LIFD) has prepaid an additional $916,666 of the principal of its $1,833,334 note payable relating to the purchase of its subsidiary Lifted Made, Kenosha, WI, using free cash flow generated by Lifted Made's operations.

LIFD

2 minute read

Filament Begins First Ever FDA-Approved Clinical Trial On Naturally-Derived Psychedelic Drugs

By Lara Goldstein

July 8, 1:09 PM

Clinical-stage natural psychedelics company Filament Health Corp.

FLHLF

2 minute read

Atai Life Sciences: Capital Raise, Share Options, Cathy Wood And More On Biotech Psychedelics Leader

By Lara Goldstein

July 7, 3:14 PM

Atai Life Sciences N.V.

ARKG

2 minute read

Elon Musk, You’re Cordially Invited To The Benzinga Cannabis Capital Conference In Chicago, No Need To RSVP, See You There?

By Maureen Meehan

July 7, 11:10 AM

If Tesla (NASDAQ: TSLA) CEO Elon Musk had not been having an ‘excruciating’ year, he might have had the good fortune to attend the very first Benzinga Cannabis Capital Conference in Toronto in April 2018.

TSLA

1 minute read

BetterLife’s Preclinical Studies Of BETR-001 For Depression Gets Additional Sponsorship By Mitacs

By Lara Goldstein

July 6, 1:58 PM

Biotech psychedelics company BetterLife Pharma Inc. (OTCQB: BETRF) in collaboration with the Carleton University Dept.

BETRF